The Global Health Innovative Technology (GHIT) Fund announced a total of approximately 750 million yen (US$6.6 million*) to invest in six partnerships to develop new lifesaving drugs for malaria and Chagas Disease, a vaccine for malaria, and diagnostics for tuberculosis […]
Recent Posts
- BIOTEC-NSTDA Welcomes Embassy of Japan and Pt.Bio Inc. to Foster Food Innovation and Genome Editing Research
06/02/2026 - NSTDA/BIOTEC Welcomes Delegations from NSFC and Embassy of the People’s Republic of China in Thailand to Foster International Research Collaboration
06/02/2026 - Embassy of Malaysia Visits BIOTEC to Strengthen Collaboration in Agriculture and Biotechnology
04/09/2026